Press Releases
Glenstar Completes Successful Initial Drilling at Wildhorse Project in Nevada
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Glenstar Minerals Inc. (CSE: GSTR) (OTCQB: GSTRF) (FSE: VO20) ("Glenstar" or the "Company") announces that the Phase 1 reverse circulation drill program at the Company's Wildhorse Project in Mineral County, Nevada, (see news release dated April 14, 2026), has been completed, with a total of six reverse circulation drill holes being completed at the Rattlesnake Zone, in addition to four holes previously reported at the Coca Cola Zone (see news release dated April 29, 2026). Each of these six holes explored the Rattlesnake Zone's down dip extension 85 to 110 meters east of outcropping mineralization which were worked by a series of historic decline developments...
Equinor ASA: Minutes from the Annual General Meeting 2026
With reference to the annual general meeting in Equinor ASA (OSE: EQNR, NYSE:EQNR) held on 12 May 2026 and the stock exchange announcement of the same date. The minutes are now finalised and enclosed hereto.
Hongli Group Inc. Reports Robust Fiscal Year 2025 Results: Revenue Grows 39% to $19.6 Million as Company Delivers $3.8 Million Profit Turnaround
WEIFANG, China, May 13, 2026 /PRNewswire/ -- Hongli Group Inc. (Nasdaq: HLP) (the "Company" or "Hongli Group"), a cold roll formed steel profile manufacturer, today announced its financial results for the fiscal year ended December 31, 2025, and the filing of its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (the "SEC") on May 13, 2026. Fiscal Year ended December 31, 2025, Full Year Highlights: Revenues for the fiscal year ended December 31, 2025, increased by 39.0% to $19.6 million compared to the prior year, driven by growth in both domestic and global markets; International sales grew by 58.2%...
CEO.CA's Inside the Boardroom: Adyton Resources Reports New Discovery of a High-Grade Gold Zone
Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc. , is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality...
Red Robin Shakes Up World Cocktail Day with New Summer Beverage Lineup
Five new margaritas and cocktails bring tropical flavors and a splash of fun just in time for summer sippin' ENGLEWOOD, Colo., May 13, 2026 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) is raising a glass this World Cocktail Day with the debut of its new summer beverage menu, arriving at all Red Robin restaurants on May 18...
LibertyStream to Participate in Upcoming Energy, Critical Minerals and Investor Conferences as U.S. Lithium Production Strategy Advances
DALLAS--(BUSINESS WIRE)---- $LIB.v #criticalminerals--LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) announces that it is scheduled to participate in a series of energy, critical-minerals, battery-supply-chain and investor conferences during May and June 2026. In connection with these events, the Company has also updated its corporate presentation, available on its website, to reflect recent announcements and ongoing progress at its field operations in Ho...
VNET Announces New Strategic Investors
BEIJING, May 13, 2026 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced that PJ Millennium I Limited ("Buyer I") and PJ Millennium II Limited ("Buyer II", together with "Buyer I", the "Buyers") have entered into a share purchase agreement (the "Share Purchase Agreement") with Success Flow International Investment Limited ("Success Flow") and Choice Faith Group Holdings Limited ("Choice Faith", together with "Success Flow", the "Sellers") to purchase from the Sellers in aggregate up to 650,424,192 Class A ordinary shares in the Company (the "Proposed Investment"), at a price of US$1.4486 per ordinary share in cash (which is equivalent to US$8.6914 per ADS). VNET also entered into a deed with the Buyers to provide certain representations and warranties and undertakings to the Buyers in connection with the Proposed Investment...
Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results
Strengthened Capital Position and Accelerating Path to Revenue NEW YORK, May 13, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc. (NASDAQ: CNTN) ("Canton Strategic Holdings" or the "Company"), the first publicly traded company to leverage Canton Coin (CC) to support the Canton Network's ability to digitize traditional financial markets, today announced its financial and operating results for the first quarter 2026 ended March 31, 2026. "We are pleased with the significant operational progress in the first quarter 2026 as we advance institutional adoption of the Canton Network while driving shareholder value," said Mark Wendland, Chairman and Chief Executive Officer of Canton Strategic Holdings...
Mitek Announces Strategic Partnership with Global Analytics Software Leader FICO to Strengthen Enterprise Fraud Defenses
SAN DIEGO--(BUSINESS WIRE)--Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification and fraud prevention, announced today that its Mitek Verified Identity Platform (MiVIP) is now available on FICO Marketplace, the industry's first marketplace for composable enterprise decisioning offerings. The listing empowers enterprises to operationalize AI and drive better outcomes by easily discovering, accessing, and deploying a wide range of pre-built offerings, including A...
QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three months ended March 31, 2026 and provided a business update. “We continued to execute during the first quarter, making meaningful progress across commercialization, regulatory execution, and clinical validation,” sai...
VENU Launches the ‘FireSuite Income Offering', Bringing Fractional FireSuite Ownership and an 11% Preferred Annual Return to Qualified Investors Nationwide
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)---- $VENU #FireSuites--Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), owner, operator, and developer of premium live entertainment destinations, today announced the launch of its FireSuite Income Offering, a fractional ownership offering providing participants with an opportunity to acquire an interest in a portion of the Company's signature Luxe FireSuitesTM across a selection of its under development venues, intended to bring the financial benefit...
Stabilization Notice -- Pre Stab UGI International LLC
[13/05/2026] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [UGI International LLC] Pre-stabilisation Period Announcement BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222 hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014)...
Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results
AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2026, which ended March 31, 2026.
Weichai Power Hong Kong International Development Co. Limited Announces Sale of Common Shares of Ballard Power Systems Inc
Hong Kong, China--(Newsfile Corp. - May 13, 2026) - Weichai Power Hong Kong International Development Co. Limited ("Weichai") announces that, through a series of transactions between May 8, 2026 and May 12, 2026, Weichai completed the disposition of an aggregate of 6,878,886 common shares (the "Common Shares") of Ballard Power Systems Inc. ("Ballard") for an average price of Cdn$5.78 per Common Share and a total disposition price of Cdn$39,737,594.05 (the "Disposition"). Immediately prior to the completion of the Disposition, Weichai owned a total of 46,131,712 Common Shares...
KBW Names Pathward Financial to its 2026 Bank Honor Roll
SIOUX FALLS, S.D.--(BUSINESS WIRE)--Pathward Financial, Inc. is among the U.S. banking institutions recognized on KBW's 2026 Bank Honor Roll.
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
Advancements across investigator-initiated studies, translational research and manufacturing activities supporting future clinical development Strengthened financial profile with continued royalty revenue growth Ended first quarter 2026 with approximately $7.3 million in cash while continuing evaluation of strategic alternatives to maximize shareholder value FRAMINGHAM, MA / ACCESS Newswire / May 13, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today reported its financial results for the quarter ended March 31, 2026 and provided a corporate update on the advancement of its innovative DNase oncology platform. Recent Highlights Generated robust translational data supporting the DNase I platform across multiple oncology settings Completed process improvement and analytical development activities supporting future clinical manufacturing readiness Established translational and biomarker insights intended to help inform and de-risk future clinical trial design Collaboration partner received approval from Israeli Ministry of Health to conduct investigator-initiated exploratory study of DNase I in combination with anti-CD19 CAR T cells in large B-cell lymphoma "We entered 2026 with a clear focus on advancing the translational, manufacturing and clinical foundation of our DNase I platform while maintaining financial discipline," said James Parslow, Interim Chief Executive Officer and Chief Financial Officer of Xenetic...
Robert Half survey: More than three-quarters of U.S. small businesses are confident about hiring, but nearly half struggle to find skilled talent
Only 12% say they have the talent they need to complete high-priority projects 54% say AI-generated applications has made hiring more difficult MENLO PARK, Calif., May 13, 2026 /PRNewswire/ -- May is National Small Business Month, and new research from talent solutions and business consulting firm Robert Half shows many small business leaders are optimistic about the year ahead, even as hiring grows more complex amid widening skills gaps and evolving technology...
Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
Mipletamig continues to perform, delivers 87% clinical benefit and 81% remission in frontline AML, with no CRS in frontline patients Executive leadership transition complete. Jeff Lamothe appointed CEO; Marvin White assumes Executive Chair $60 million equity line of credit enhances financial flexibility and extends access to capital through achievement of key catalysts into 2029 SEATTLE, WA / ACCESS Newswire / May 13, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today provided a business update...
nLIGHT, Inc. Named ‘Enterprise Tech Company of the Year' at 2026 Oregon Tech Awards
CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission-critical directed energy, optical sensing, and advanced manufacturing applications, today announced it has been named ‘Enterprise Tech Company of the Year' at the 2026 Oregon Tech Awards, presented by the Technology Association of Oregon (TAO). The Oregon Tech Awards are TAO's flagship annual event and are widely regarded as Oregon's most prestigious recognition program for technology...
Bank of America Stadium Reports Efficient Game-Day Operations Using Evolv Technology
WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, shares new insights into the operational impact at Bank of America Stadium driven by ongoing use of Evolv Express for efficient, high-volume fan entry security screening. As an early adopter of Evolv Express, purchasing Gen1 in 2021, the stadium recently announced their renewal and upgrade to Evolv Express G...
Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion
BOCA RATON, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, today announced the strategic commercial positioning of its soon to be acquired Aetherium Medical platform as a direct response to one of the most significant structural shifts in global healthcare: the explosive, government-backed surge in medical tourism across Asia-Pacific, a global market now projected to reach $273.7 billion by 2032...
Candel Therapeutics to Present at Upcoming Investor Conferences
NEEDHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel's President and Chief Executive Officer, will present and participate in one-on-one meetings with investors at upcoming investor conferences...
Bluesphere Ventures Selects Stem for New York VDER Storage Advisory
HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that it has entered into a new services agreement with Bluesphere Ventures to support its portfolio of standalone battery energy storage projects participating in New York's Value of Distributed Energy Resources (VDER) program. Under the agreement, Stem will provide revenue modeling, market analysis, and intelligence across Bluesphere Ventures' pipeline of battery...
Wayfair Announces Proposed Offering of $400 Million Senior Secured Notes
BOSTON, May 13, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE: W) (the "Company," "we" or "Wayfair") today announced that its subsidiary, Wayfair LLC (the "Issuer"), intends to offer, subject to market and other conditions, $400 million in aggregate principal amount of senior secured notes due 2034 (the "Notes") in a private offering. We intend to use the net proceeds from the Notes offering to repay a portion of our existing indebtedness and for other general corporate purposes...
Alight Adds Cylinder and Leap to Partner Network
CHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, today announced the expansion of its Alight Partner Network with the addition of Cylinder Health and Leap, two partners that strengthen Alight's ability to help employers deliver high-impact health solutions. The Alight Partner Network offers a curated ecosystem of solutions designed to help employers deliver a more connected and engaging employee experie...
Allegro MicroSystems to Present at TD Cowen's 54th Annual Technology, Media & Telecom Conference on Wednesday, May 27, 2026
MANCHESTER, N.H., May 13, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company will present at TD Cowen's 54th Annual Technology, Media & Telecom Conference on Wednesday, May 27, 2026 at the InterContinental New York Barclay in New York, NY. Derek D'Antilio, EVP and Chief Financial Officer, is scheduled to participate in a fireside chat at 1:15 PM Eastern Time (ET)...
Howmet Aerospace to Present at Bernstein's 42nd Annual Strategic Decisions Conference (SDC)
PITTSBURGH, May 13, 2026 /PRNewswire/ -- Howmet Aerospace Inc. (NYSE: HWM) announced today that John C. Plant, Executive Chairman and Chief Executive Officer, will speak at Bernstein's 42nd Annual Strategic Decisions Conference (SDC) on Wednesday, May 27th, 2026, at 8:00 AM ET.
Century Therapeutics Reports First Quarter Financial Results and Business Updates
PHILADELPHIA, May 13, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer, today reported financial results for the first quarter ended March 31, 2026, and recent business highlights...
Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing
MORRISTOWN, N.J., May 13, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (the "Company" or "Whitehawk") (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced that it has entered into a securities purchase agreement with certain qualified institutional buyers and accredited investors for a private investment in public equity ("PIPE") financing that is expected to result in gross proceeds of approximately $87.5 million, before deducting placement agent fees and other private placement expenses...
Decibel to Announce First Quarter 2026 Financial Results on May 21, 2026
CALGARY, AB, May 13, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in Canadian branded cannabis manufactured products and global medical exports, announces that it will report its first quarter 2026 financial results pre-market on Thursday, May 21, 2026. The Company will host a live conference call to discuss the results at 10:00 a.m...
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced that management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20th, 2026, at 2:05 p.m. ET...
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the first quarter ended March 31, 2026 and provided corporate updates. “We are very pleased with the meaningful progress we continue to make in advancing TA-ERT toward our planned biologics license application subm...
Guerrilla RF High-Power GaN HEMT Models Now Available in Modelithics COMPLETE Library™
TAMPA, Fla.--(BUSINESS WIRE)---- $GUER--Guerrilla RF High-Power GaN HEMT Models Now Available in Modelithics COMPLETE Library™.
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
- Advanced "dabogratinib 3x3" strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH - - First LG-UTUC patient dosed with dabogratinib in SURF303; initial results expected in 2027 - - Initial Ph2 data readout from SURF302 expected in August 2026 (n>20 enrolled to date) - - Initial Ph2 data readout from safety sentinel cohort in BEACH301 expected in Q4 2026 (4th dose level cleared) - - Cash, cash equivalents and marketable securities of $383.5 million at Q1 2026; runway into 2H 2028 - CARLSBAD, Calif., May 13, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today reported financial results for the first quarter ended March 31, 2026, and highlighted recent corporate progress...
Ishan Technologies Boosts Service Agility and Customer Experiences with Oracle
Oracle Communications to support Indian ICT leader's goal to optimize operations and expedite delivery of new digital services AHMEDABAD, India and AUSTIN, Texas, May 13, 2026 /PRNewswire/ -- Ishan Technologies, a rapidly evolving information and communication technology (ICT) company, has selected Oracle Communications to drive an ambitious, end-to-end digital transformation initiative. The collaboration aims to modernize charging and billing, enabling faster time-to-market for new offerings, more flexible pricing and discount models, and improved operational efficiency across Ishan's portfolio...
Coty "Supercharge with AI" Enterprise Upskilling Program Wins Newsweek AI Impact Award
NEW YORK--(BUSINESS WIRE)--Coty Inc. (NYSE: COTY) (Paris: COTY), (“Coty” or “the Company”) one of the world's largest beauty companies, today announced that its enterprise AI literacy program, "Supercharge with AI: Scaling Enterprise-Wide AI Literacy & Adoption to Transform How Coty Works," (Supercharge with AI), has been named a winner of Newsweek's AI Impact Award in the “AI Workplace: Best Outcomes, Employee Engagement” category. The award program recognizes organizations applying artifi...
High-Trend International Group Announces Pricing of $15 Million Registered Direct Offering with Global Institutional Investors
NEW YORK, May 13, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global ocean transportation company, today announced that it has entered into securities purchase agreements with global institutional investors for the purchase and sale of 2,307,700 of the Company's Class A Ordinary Shares ("Ordinary Shares") at a purchase price of $6.50 per Ordinary Share in a registered direct offering. The gross proceeds from the offering are expected to be approximately $15 million, before deducting placement agent commissions and other offering expenses...
Adtran expands SDG 8700 Series to deliver Wi-Fi 7 at scale
HUNTSVILLE, Ala.--(BUSINESS WIRE)-- #5G--Adtran today announced an expansion of its SDG 8700 Series, extending Wi-Fi 7 across a broader range of residential service tiers and deployment models. The expanded portfolio introduces new 2.5Gbit/s and 10Gbit/s Wi-Fi 7 platforms designed to support the full spectrum of multigigabit services – from entry-level offerings to premium tiers – across residential, SMB, MDU and community Wi-Fi deployments. As service providers enter a new access refresh cycle, Wi-F...
Inter Venezuela Taps Harmonic for PON-Based Mobile Backhaul Service to Support 5G Growth
SAN JOSE, Calif., May 13, 2026 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Inter Venezuela, the largest private Internet service provider in Venezuela, is powering its new nationwide XGS-PON-based mobile backhaul service with Harmonic's cOS™ virtualized core and portfolio of fiber solutions...
PagBank reports recurring net income of R$ 575 million in 1Q26, driven by revenue growth and efficiency gains
Digital banking platform surpasses R$ 42 billion in deposits and R$ 5 billion in loan portfolio, supported by the expansion of its banking platform and operating leverage during the period SÃO PAULO, May 13, 2026 /PRNewswire/ -- PagBank (NYSE: PAGS), one of Brazil's largest digital banking platforms and a specialist in serving Brazilian entrepreneurs, announces its results for the first quarter of 2026 (1Q26). During the quarter, recurring net income totaled R$ 575 million, up 4% year over year...
NiCE and Konecta Partner to Scale AI-First Customer Experience Through Agentic Automation
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) NiCE today announced a strategic partnership with Konecta, a global leader in customer experience (CX) and digital services, to accelerate the deployment of next-generation, AI-powered solutions across global markets. At the core of this partnership is NiCE's CX AI platform, CXone, recognized as a leading Contact Center as a Service (CCaaS) solution, along with NiCE Cognigy's cutting-edge generative and agentic AI technology. Bringing these ca...
Evolv Technology to Host Investor Day on June 9, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it will host Evolv Technology Investor Day 2026 on Tuesday, June 9, 2026 from 9:00 a.m. to 12:00 p.m. Eastern Time. Members of the Company's management team will provide an overview of the Company's vision, strategy, growth initiatives, business trends, products and technology as wel...
Toyota African Foundation Sued for Misappropriating Mobility for Africa's Proprietary Rural EV Technology
LOS ANGELES--(BUSINESS WIRE)--Brithem LLP has filed a lawsuit in the United States District Court for the Central District of California alleging that The Toyota Mobility Foundation (TMF) and its outside consultants misappropriated trade secrets and other proprietary information of the small Zimbabwean social enterprise company Mobility for Africa (MFA), which is dedicated to improving the lives of African women and rural communities by providing a sustainable ecosystem of EV mobility. The comp...
CRH Appoints Aylwyn Bryan as CFO
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials, announced the appointment of Aylwyn Bryan as its Chief Financial Officer, effective May 12, 2026. Bryan has over 25 years of financial leadership experience, including the past 14 years with CRH. Most recently he served as CFO of CRH's Americas Division and previously as Head of Group Finance and Group Tax Director. As CFO, Bryan will continue to play a critical role in advancing CRH's strategy and operation...
Innoviz Technologies Announces Advanced Development Program Combining LiDAR and On-Sensor Perception Software for Future OEM Autonomous Vehicle Program
Innoviz enters into a new agreement with a leading autonomous driving technology company to evaluate the development of enhanced on-sensor perception software TEL AVIV, Israel, May 13, 2026 /PRNewswire/ -- Innoviz Technologies Ltd. (NASDAQ: INVZ) (the "Company" or "Innoviz"), a leading supplier of high-performance, automotive-grade LiDAR sensor platforms, today announced a new software development agreement with a leading autonomous driving technology company...
Leatt Corp Announces Share Repurchase Program
CAPE TOWN, South Africa, May 13, 2026 /PRNewswire/ -- Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe protective equipment for MOTO, MTB, ADV, and a wide range of extreme and high-velocity sports, today announced that its Board of Directors has authorized a new share repurchase program of the Company's outstanding common stock. "We are pleased that our Board of Directors has authorized the continuation of our previously announced share repurchase program which authorized a repurchase of common stock to the value of $ 750,000," said Sean Macdonald, Chief Executive Officer...
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
– Presentations Examine Findings From the Pediatric Phase 2 Study, As Well As Factors Associated With Enhanced LDL-C Reductions in Adult Patients Enrolled in Clear Outcomes – – Pediatric Phase 2 Study Demonstrated Bempedoic Acid Treatment Reduced LDL-C in Children with Heterozygous Familial Hypercholesterolemia (HeFH) Congruent with Reductions in Adult Exposures – – New Analyses from CLEAR Outcomes Trial Identified Factors Associated With Enhanced LDL-C Reductions in Adult Patients – ANN ARBOR, Mich., May 13, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that two new abstracts and three encore abstracts have been accepted for presentation at the European Atherosclerosis Society (EAS) Congress 2026 taking place on May 24-27, 2026, in Athens, Greece...
Enphase Energy Opens U.S. Pre-Orders for GaN-Based 548 VA IQ9S Commercial Microinverters
FREMONT, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today opened U.S. pre-orders for the new IQ9S-3P™ Commercial Microinverter, its most powerful microinverter to date.
Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
Preliminary blinded CR rate for the first 45 subjects in the trial approximates 30% and represents ~67% improvement vs. standard of care First 45-subject data unblinding expected before June 30, 2026 Program targets high-unmet-need AML population, including R/R Venetoclax subjects Recruitment of Part A continues to the target 90 subjects in Q3 2026 with 56 or 62% subjects recruited and randomized Continued absence of cardiotoxicity and high efficacy expected to position Annamycin as a “significant advancement” in AML treatment HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it is approaching the first unblinding of data from its pivotal Phase 2B/3 “MIRACLE” trial evaluating Annamycin in combination with cytarabine for the treatment of subjects that have been relapsed or refractory to their primary line of treatment for acute myeloid leukemia (R/R AML)...
Diginex Appoints Archana Kotecha as Chief Impact Officer to Advance Human Rights and Scale Supply Chain Solutions in a $9.6B Market
Appointment strengthens Diginex's leadership team and reinforces Company's ambition to scale its global impact and compliance capabilities, building on existing partnerships with leading global companies, following acquisition of The Remedy Project. It comes against a backdrop of rising global investment in human rights and supply chain due diligence, a fast‑growing $3.8 billion market in 2025 (Dataintelo), driven by tighter regulation, increased investor scrutiny and demand for responsible sourcing...
Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1)
New York, May 13, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1). The research summary below is from an issuer-sponsored report commissioned by Almonty Industries, Inc. and produced by Diamond Equity Research...
Swarmer Reports First Quarter Financial Results
AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (“Swarmer” or the “Company”) (Nasdaq: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced financial results for the quarter ended March 31, 2026 (“Q1 2026”), and discussed recent business developments. Management Commentary Swarmer President & U.S. CEO Alex Fink stated: “The first quarter of 2026 represented an important step forward for Swarmer as we completed our initial public offering, strengthened our leadership team and continued to expand our presence within the autonomous systems ecosystem...
The Woodworkers You Don't Want: Inside the World of Carpenter Ants with Orkin Canada
TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- With spring here, homeowners across Canada may begin noticing increased ant activity in and around their homes. While many ants are harmless, experts warn that carpenter ants are one pest that should never be ignored.
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better protect against severe allergic reactions that can lead to anaphylaxis, today announced the appointment of Donn Casale as President, effective June 1, 2026. Richard Lowenthal will continue to lead ARS Pharma as Chief Executive Officer...
Sprinklr Announces Date of First Quarter Financial Results
NEW YORK--(BUSINESS WIRE)---- $CXM #CX--Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company's first quarter financial results will be released before market open on June 3, 2026. The company's earnings press release will be made available on the Sprinklr Investor Relations website at investors.sprinklr.com. Sprinklr will host a conference call to discuss its results at 8:30am ET the same day. Interested parties m...
Union Pacific Corporation CEO Jim Vena and CFO Jennifer Hamann to Address the Wolfe Research 19th Annual Global Transportation & Industrials Conference
OMAHA, Neb.--(BUSINESS WIRE)--Jim Vena, chief executive officer and Jennifer Hamann, executive vice president and chief financial officer, of Union Pacific Corporation (NYSE: UNP) will address the Wolfe Research 19th Annual Global Transportation & Industrials Conference on Wednesday, May 20, 2026, at 9:50 a.m. ET. A live webcast of the presentation will be available in the investor relations section of Union Pacific's website at https://investor.unionpacific.com. A replay of the audio webca...
MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate
Peer-reviewed publication highlights preclinical findings demonstrating weight loss, lipid normalization, and reduction of compulsive feeding and nicotine-seeking behaviors MIAMI, FL / ACCESS Newswire / May 13, 2026 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on the development of investigational therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the acceptance and publication of a peer-reviewed manuscript describing the preclinical pharmacology and activity of SKNY-1, the Company's oral investigational drug candidate being evaluated for obesity and nicotine addiction, in the International Journal of Molecular Sciences. The publication, titled "SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity," describes in vitro pharmacologic characterization and in vivo preclinical findings observed in an MC4R-deficient zebrafish model exhibiting obesity-associated metabolic and reward-related phenotypes...
Manulife Releases 2025 Sustainability Report and Public Accountability Statement
Report shares firm's continued progress toward generating long-term value for its business, customers, communities, colleagues, and shareholders C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 TORONTO, May 13, 2026 /PRNewswire/ - Manulife today released its 2025 Sustainability Report and its 2025 Public Accountability Statement, detailing its approach, performance, and achievements relative to its sustainability strategy. Highlights from the firm's 2025 Sustainability Report that support Manulife's Impact Agenda to empower health and well-being, support financial resilience, and contribute to a healthier planet include the followingi: Launched the Manulife Longevity Institute to advance research, thought leadership, innovation, advocacy, and community partnerships focused on longevity, committing $350 million through 2030 to help people live longer, healthier, and more financially secure lives...
BTU Acquires Property East of Great Bear's World Class Dixie Gold Deposit and Their New Strider Gold Discovery
VANCOUVER, BC / ACCESS Newswire / May 13, 2026 / BTU METALS CORP. ("BTU" or the "Company") (TSX-V:BTU)(OTCQB:BTUMF) is pleased to announce it has signed an option to acquire a 100% interest in the Dixie East Block 2 property located approximately 30 km east of the Kinross ‘World Class' Great Bear ("GBR") Dixie Project, southeast of Red Lake, Ontario...
Bloomia Holdings, Inc. Announces March 31, 2026 Financial Results
MINNEAPOLIS, MN / ACCESS Newswire / May 13, 2026 / Bloomia Holdings, Inc. (Nasdaq:TULP) ("Bloomia Holdings" or the "Company") today announced its financial results for the third fiscal quarter ended March 31, 2026. Overview Three Months Ended March 31, 2026 Net revenue was $14.4 million compared to $12.4 million in the three months ended March 31, 2025...
iA Financial Group Cautions Investors Regarding Ocehan LLC “Mini-Tender” Offer at a Significant Discount to Market Price
QUEBEC CITY--(BUSINESS WIRE)--iA Financial Group (TSX: IAG) has been notified of a new unsolicited mini-tender offer made by Ocehan LLC (“Ocehan”) to purchase up to 50,000 common shares of iA Financial Group, representing approximately 0.06% of the common shares outstanding, at a price of $ 130.00 per share, representing an aggregate purchase price of $ 6.5 million. iA Financial Group is not associated with Ocehan and does not recommend or endorse in any way the acceptance of this restricted te...
Starfighters Space Engages Integrated Launch Solutions (ILS) to Advance STARLAUNCH Pathway
CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. ("Starfighters" or the "Company") (NYSE American: FJET), the innovative aerospace company, owner and operator of the world's largest fleet of commercial supersonic aircraft, announced today that it has engaged Integrated Launch Solutions, Inc. ("ILS") to provide engineering and technical integration support as Starfighters advances the STARLAUNCH pathway from design and analysis toward flight and launch services. Key Takeaways Star...
Gold Reserve Announces Board Approval of Spin-Out Transactions
PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) is pleased to announce that its board of directors has approved the previously announced potential spin-out (the “American Heralds Spin-Out”) of its new U.S.-domiciled company, American Heralds Mining Corporation (“American Heralds”). As described in the Company's prior news release, it is intended that American Heralds will hold Gold Reserve's mining interests in Ve...
Quantum Cyber N.V. Secures Exclusive Autonomous Drone Platform as Trump Administration Seeks $55 Billion for Drone Warfare
Company Executes IP License Agreement with BP United Inc.; Quantum Antenna Technology Company Executes IP License Agreement with BP United Inc.; Quantum Antenna Technology
Gildan Announces the Publication of its 2025 Sustainability Report Highlighting Continued Progress Towards Key Social and Environmental Targets¹
MONTREAL, May 13, 2026 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or “the Company”) is pleased to announce the publication of its 22nd Sustainability Report¹, highlighting progress under its Next Generation Sustainability strategy² and ongoing efforts to create long-term value...
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
- CDMO program advances to Stage 2 of development agreement valued at $1.125 million -Advancement of sustainable solution for the production of saffron, one of the world's most valuable and health-promoting botanicals - In addition to future commercial manufacturing royalties, BioHarvest also holds a 25% ownership position in Saffron Composition Vancouver, British Columbia and Rehovot, Israel---(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has completed Stage 1 under a multi-stage development agreement, successfully establishing a stable saffron cell bank for potential nutraceutical and culinary applications. The development partner is SaffronTech, a company pioneering advanced cultivation methods for saffron, one of the world's most valuable and health-promoting botanicals...
TNR Gold Announces TSX Venture Exchange Conditional Approval of Altius Strategic Investment
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - TNR Gold Corp. (TSXV: TNR) ("TNR", "TNR Gold" or the "Company") is pleased to announce that further to its April 6, 2026 news release regarding its strategic private placement by Altius Resources Inc. ("Altius Resources"), a wholly-owned subsidiary of Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) ("Altius"), TNR Gold has now received TSX Venture Exchange conditional approval to complete the private placement (the "Private Placement"). The Private Placement is expected to close no sooner than 5 trading days from the date of this news release...
AGCO to Present at the J.P. Morgan 2026 Global Technology, Media and Communications Conference
DULUTH, Ga., May 13, 2026 /PRNewswire/ -- AGCO (NYSE: AGCO) today announced it will participate in the J.P.
Zodiac Gold Intersects Near-Surface High-Grade Gold in First-Ever Drilling at Ben Ben, Confirming 1km Mineralized Trend Within a 16km District-Scale Trend
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Zodiac Gold Inc. (TSXV: ZAU) (OTCQB: ZAUIF) (FSE: K19) ("Zodiac Gold" or the "Company"), a West African gold exploration company, is pleased to report initial assay results from the first-ever diamond drilling program at its Ben Ben target, part of the Company's flagship Todi Gold Project in Liberia. Key Highlights: Early results at Ben Ben continue to illustrate the strong potential of the 16km corridor from the Arthington discovery, through Ben Ben, to Youth Camp (Map 1)...
Inverite Insights Engages Canadian Investor Relations Firm Investor Cubed (I3)
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRF) (FSE: 2V0) ("Inverite" or the "Company") a leading AI-driven software provider utilizing real-time financial data to support risk, verification, and fraud-prevention decisions. is pleased to announce that it has engaged Investor Cubed Inc. ("Investor Cubed") to provide investor relations and shareholder communications services in Canada...
Pacific Empire Announces First Tranche Closing of Non-Brokered Private Placement and Engagement of Equity Exploration Consultants Ltd.
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Pacific Empire Minerals Corp. (TSXV: PEMC) ("Pacific Empire", "PEMC" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement financing for aggregate gross proceeds of up to $4,500,000 (the "Offering"). Pursuant to the First Tranche, the Company raised an aggregate of $3,438,999.95 in gross proceeds and issued: 48,809,230 flow-through common shares (the "FT Shares") at a price of $0.065 per FT Share for gross proceeds of $3,172,599.95; and 4,440,000 non-flow-through common shares (the "Common Shares") at a price of $0.06 per Common Share for gross proceeds of $266,400.00...
Hemisphere Energy Declares Quarterly Dividend, Announces 2026 First Quarter Results and Provides Guidance Update
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) ("Hemisphere" or the "Company") declares a quarterly payment to shareholders, announces its financial and operating results for the first quarter ended March 31, 2026, and provides guidance update. Quarterly Dividend Hemisphere is pleased to announce that its Board of Directors has approved a quarterly cash dividend of $0.025 per common share in accordance with the Company's dividend policy...
MinuteClinic highlights access and outcomes in clinically supervised weight-loss program
In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic, the medical clinic inside select CVS Pharmacy (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care...
CEO.CA's Inside the Boardroom: Royal Road Minerals: Porphyry Copper Cluster Identified Across a 6km Footprint
Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc. , is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality...
ImagineAR Provides Corporate Update and Reports Progress on Patent Portfolio
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - ImagineAR Inc. (CSE: IP) (the "Company" or "ImagineAR"), a developer of augmented reality technology, provides the following corporate update and reported progress on the advancement of its U.S. patent portfolio. In 2026, the Company is expected to advance the technical and commercial foundation of its core platform while undertaking a disciplined review of its cost structure and operating priorities...
Dominari Holdings Issues Shareholder Letter
Company Reports Revenue of $35.8 million up 395% from prior year Total Capital invested across all SPV Series: approximately $292 million Record Date of May 15 th for $9 Million Dividend Payment NEW YORK, May 13, 2026 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today issued the following letter to shareholders: Dear Shareholder, As we approach mid-year, I want to take this opportunity to thank you for being a Dominari shareholder and provide you with some updates. 10Q Summary The year is off to a strong start...
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
MADRID and CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that updated positive clinical data from two Phase Ib clinical trials evaluating its selective LSD1 inhibitor iadademstat in acute myeloid leukemia (AML) will be presented in two poster sessions at the European Hematology Association (EHA) Annual Congress, taking place June 11-14, 2026 in Stockholm, Sweden. “We are encouraged by the updated findings from both the ALICE-2 and FRIDA trials, which continue to support the clinical activity and favorable safety profile of iadademstat-based combinations in AML,” said Carlos Buesa, Chief Executive Officer of Oryzon. “We look forward to presenting updated data at EHA 2026 from a larger patient cohort in the ALICE-2 study, likely representing approximately 75–80% of the planned enrollment, which we believe will provide a more mature assessment of both safety and efficacy of the triplet combination. Based on the strength of the emerging data, the Company is envisaging an accelerated clinical development plan for iadademstat in the first-line AML setting.”
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc., through its subsidiary, Immunodiagnostic Systems (IDS), today announced that it received clearance from the U.S. Food and Drug Administration (FDA) for its Total Testosterone automated chemiluminescence immunoassay (ChLIA). This offering complements the Company's FDA-cleared ChLIA tests for free testosterone and sex hormone-binding globulin (SHBG), delivering a first of its kind, complete solution for testosterone-related disorders on a single pla...
TTEC Digital Signs Strategic Collaboration Agreement with AWS to Accelerate Amazon Connect Adoption
AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- TTEC, a leading global consulting, technology, and managed services company delivering solutions at the intersection of data, AI, and customer experience (CX), today announced that TTEC Digital has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS), with plans to accelerate Amazon Connect adoption through AI-powered customer experience transformation. "TTEC Digital's depth of experience on Amazon Connect is rooted in our history as one of the platform's earliest collaborators...
Photronics to Report Fiscal Second Quarter 2026 Results on May 28, 2026
BROOKFIELD, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (Nasdaq: PLAB), a worldwide leader in photomask technologies and solutions, is scheduled to announce financial results for the second quarter of fiscal 2026 on Thursday, May 28, 2026, before the market opens.
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor.
Foremost Clean Energy Announces Expansion of the Tuning Fork Uranium Zone at Hatchet Lake South
TF-26-36 Returns 0.18% eU₃O₈ Over 2.9 Metres, Extending Northern Extent of Uranium Mineralization by ~100m; ~600m of Strike Length Remains Open to the South TF-26-36 Returns 0.18% eU₃O₈ Over 2.9 Metres, Extending Northern Extent of Uranium Mineralization by ~100m; ~600m of Strike Length Remains Open to the South
One Stop Systems to Attend Special Operations Forces Week on May 19 - 21
Showcasing rugged AI Compute Solutions “Built for the edge, engineered for the fight” at Booth #5006 OSS to demonstrate rugged Edge AI, sensor fusion, and tactical compute capabilities with integrated technology partners ESCONDIDO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged high performance compute (“HPC”) for artificial intelligence (“AI”), machine learning (“ML”) and sensor processing at the edge, today announced it will showcase a range of mission-ready products and integrated solutions designed to support modern warfighters at Special Operations Forces Week, taking place May 19–21, 2026, at the Tampa Convention Center...
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of excellence
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in analyst-led fireside chats at the following three healthcare conferences: 2026 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20th at 8:30AM ET...
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization. The partnership will leverage Charles River's expertise in biologics and cell therapy GMP testing to support MEDIPOST's global cell therapy pipeline, starting i...
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial...
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ...
Cerence AI to Participate in TD Cowen 54th Annual Technology, Media & Telecom Conference
BURLINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the Company will participate in the TD Cowen 54th Annual Technology, Media & Telecom Conference in New York City...
ICON expands US early phase research capabilities with new clinic and outpatient centres
DUBLIN & SAN ANTONIO--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas. These new, purpose-built clinics will significantly expand ICON's capacity to conduct first-in-human, healthy participant, and patient cohort stu...
Abacus Global Management to Participate in the 26th Annual B. Riley Investor Conference
ORLANDO, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NYSE: ABX), a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services with a focus on longevity-based assets and personalized financial planning, today announced that it will participate in the 26th Annual B...
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027 Hosting virtual investor webinar discussing LMs program with key opinion leader (KOL) perspectives on May 19, 2026 at 4:30 pm ET Interim safety and durability data from STARBORN-1 trial of TARA-002 in LMs to be presented at the International Society for the Study of Vascular Anomalies (ISSVA) World Congress 2026 in May Company expects to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial and initiate the ADVANCED-3 registrational trial in BCG-Naïve patients in 2H 2026 Presenting updated 12-month data from Phase 2 ADVANCED-2 trial of TARA-002 in patients with high-grade, BCG-Naïve non-muscle invasive bladder cancer (NMIBC) at the American Urological Association (AUA) Annual Meeting 2026 in May Cash, cash equivalents and investments of approximately $177 million as of March 31, 2026, expected to support planned operations into 2028 NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2026. “We're pleased with the productive discussions we've had with the FDA around TARA-002 in LMs,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics...
Banks Are Moving to a Dual Workforce Model, nCino's Inaugural AI in Banking Benchmark Shows
Nearly 9 in 10 senior banking executives say AI Agents are the future, but only 1 in 5 are currently tying it to revenue Barriers remain to turn AI momentum into measurable ROI CHARLOTTE, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, today released its inaugural “nCino AI in Banking Benchmark,” which revealed that the majority of bankers (89%) see a future defined by a dual workforce of AI agents and humans within five years...
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadership BOCA RATON, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- INmune Bio, a clinical-stage biotechnology company developing treatments that harness the patient's innate immune system to fight disease, today announced it has been named a founding member of the American Biotech Innovation Alliance (ABIA)...
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
64.5% Probability of Remaining Event-Free at Three Years by Kaplan-Meier Analysis After Achieving Complete Response at Three Months First and Only FDA-Approved Medicine for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer PRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd...
Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts...
SailPoint Announces Date of Fiscal First Quarter 2027 Earnings Conference Call and Investor Day
AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, will report its fiscal first quarter 2027 financial results and outlook before the US markets open on Tuesday, June 9, 2026. SailPoint will host a conference call that day at 8:30 a.m...
AirJoule Technologies Schedules Release of First Quarter 2026 Results and Conference Call
RONAN, Mont., May 13, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading platform technology that unleashes the power of water from air, today announced that it will report its first quarter 2026 results after market close on Thursday, May 14, 2026...